Laurence Lejeune

1.2k citations
16 papers · 1.0k indexed · h-index 13
Topics
Virus-based gene therapy research (5 papers)Mesenchymal stem cell research (5 papers)Protease and Inhibitor Mechanisms (3 papers)

In The Last Decade

Laurence Lejeune

16 papers receiving 980 citations

Peers

Laurence Lejeune
Comparison fields: 5 of 67
  • Genetics 645
  • Molecular Biology 370
  • Surgery 268
  • Oncology 181
  • Immunology 144
Replace Anthony S. Perry with:
Anthony S. Perry United States
Myoung Woo Lee South Korea
Aisha Nasef France
S. Becchetti Italy
Akiko Meguro Japan
In Keun Jang South Korea
Rosa María Pérez Yáñez Spain
Zohair Selmani France
Roxana Bistrian Germany
Basabi Maitra United States
Laurence Lejeune relative to Anthony S. Perry United States Anthony S. Perry's profile →
Citations per field
00.5×1.5×
Anthony S. Perry · 1×
Citations per year

Countries citing papers authored by Laurence Lejeune

Since Specialization
Citations

This map shows the geographic impact of Laurence Lejeune's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurence Lejeune with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurence Lejeune more than expected).

Fields of papers citing papers by Laurence Lejeune

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurence Lejeune. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurence Lejeune. The network helps show where Laurence Lejeune may publish in the future.

Co-authorship network of co-authors of Laurence Lejeune

This figure shows the co-authorship network connecting the top 25 collaborators of Laurence Lejeune. A scholar is included among the top collaborators of Laurence Lejeune based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurence Lejeune. Laurence Lejeune is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 2
2 17
3 44
4 4
5 69
6 26
7 445
8 40
9 27
10 79
11 167
12 1
13 15
14 13
15 27
16 25

About Laurence Lejeune

Laurence Lejeune is a scholar working on Genetics, Immunology and Allergy and Hematology, having authored 16 papers that have together received 1.0k indexed citations. Recurring topics across this work include Virus-based gene therapy research (5 papers), Mesenchymal stem cell research (5 papers) and Protease and Inhibitor Mechanisms (3 papers). The work is most often cited by research in Genetics (645 citations), Developmental Neuroscience (40 citations) and Hematology (103 citations). Laurence Lejeune has collaborated with scholars based in Canada, France and United States. Frequent co-authors include Jacques Galipeau, Nicoletta Eliopoulos, John Stagg, Sandra Pommey, Daniel Martineau, Kevin Lachapelle, A. Alkhaldi, Borhane Annabi, André Paquin and Mayya Mériane. Their work appears in journals such as Blood, The Journal of Immunology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026